JP2021534165A5 - - Google Patents
Info
- Publication number
- JP2021534165A5 JP2021534165A5 JP2021507775A JP2021507775A JP2021534165A5 JP 2021534165 A5 JP2021534165 A5 JP 2021534165A5 JP 2021507775 A JP2021507775 A JP 2021507775A JP 2021507775 A JP2021507775 A JP 2021507775A JP 2021534165 A5 JP2021534165 A5 JP 2021534165A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- months
- antibody
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862765093P | 2018-08-16 | 2018-08-16 | |
| US62/765,093 | 2018-08-16 | ||
| PCT/US2019/046467 WO2020037024A1 (en) | 2018-08-16 | 2019-08-14 | Anti-tissue factor antibody-drug conjugates and their use in the treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021534165A JP2021534165A (ja) | 2021-12-09 |
| JP2021534165A5 true JP2021534165A5 (cg-RX-API-DMAC7.html) | 2022-08-12 |
Family
ID=69525825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021507775A Pending JP2021534165A (ja) | 2018-08-16 | 2019-08-14 | 抗組織因子抗体−薬物コンジュゲートおよびがんの治療におけるその使用 |
Country Status (13)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI841554B (zh) | 2018-03-21 | 2024-05-11 | 丹麥商珍美寶股份有限公司 | 以鉑為主之劑與抗組織因子抗體-藥物共軛物的組合治療癌症之方法 |
| JP7460608B2 (ja) | 2018-05-07 | 2024-04-02 | ジェンマブ エー/エス | 抗pd-1抗体と抗組織因子抗体-薬物コンジュゲートとの組み合わせを用いるがんの治療方法 |
| TWI844571B (zh) | 2018-10-30 | 2024-06-11 | 丹麥商珍美寶股份有限公司 | 使用抗血管內皮生長因子(vegf)抗體與抗組織因子(tf)抗體-藥物共軛體之組合以治療癌症之方法 |
| JPWO2021200131A1 (cg-RX-API-DMAC7.html) * | 2020-03-30 | 2021-10-07 | ||
| US20230322933A1 (en) | 2020-06-04 | 2023-10-12 | Bioinvent International Ab | Model for prediction of tolerability issues in connection with intravenous administration of therapeutic antibodies |
| EP3919077A1 (en) | 2020-06-04 | 2021-12-08 | BioInvent International AB | Model for prediction of tolerability issues in connection with intravenous administration of therapeutic antibodies |
| JP2024510435A (ja) | 2021-03-18 | 2024-03-07 | シージェン インコーポレイテッド | 生体活性化合物の内部移行複合体からの選択的薬物放出 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA109633C2 (uk) * | 2008-12-09 | 2015-09-25 | Антитіло людини проти тканинного фактора | |
| JP6055404B2 (ja) * | 2010-06-15 | 2016-12-27 | ゲンマブ エー/エス | 組織因子に対するヒト抗体薬物結合体 |
| SI3071237T1 (sl) * | 2013-11-21 | 2024-11-29 | Genmab A/S | Liofilizirana formulacija konjugata protitelo-zdravilo |
| DK3151865T3 (da) * | 2014-05-22 | 2021-10-25 | Byondis Bv | Stedsspecifik konjugation af linker medicin til antistof og resulterende adcs |
| HUE055109T2 (hu) * | 2015-09-11 | 2021-11-29 | Genmab As | Adagolási rendek TF elleni antitest és gyógyszer konjugátumaihoz |
| BR112020008593A2 (pt) * | 2017-11-02 | 2020-10-20 | Genmab A/S | método de tratamento de câncer cervical em um indivíduo |
| KR20240134250A (ko) * | 2018-01-04 | 2024-09-06 | 아이코닉 테라퓨틱스, 인코포레이티드 | 항-조직 인자 항체, 항체-약물 결합체, 및 관련 방법 |
-
2019
- 2019-08-14 EA EA202190102A patent/EA202190102A1/ru unknown
- 2019-08-14 AU AU2019321442A patent/AU2019321442A1/en not_active Abandoned
- 2019-08-14 JP JP2021507775A patent/JP2021534165A/ja active Pending
- 2019-08-14 MX MX2021001058A patent/MX2021001058A/es unknown
- 2019-08-14 US US17/268,387 patent/US20210308208A1/en not_active Abandoned
- 2019-08-14 EP EP19849100.3A patent/EP3836950A4/en not_active Withdrawn
- 2019-08-14 SG SG11202101428UA patent/SG11202101428UA/en unknown
- 2019-08-14 CA CA3109116A patent/CA3109116A1/en active Pending
- 2019-08-14 KR KR1020217007245A patent/KR20210046016A/ko not_active Withdrawn
- 2019-08-14 WO PCT/US2019/046467 patent/WO2020037024A1/en not_active Ceased
- 2019-08-14 CN CN201980054479.8A patent/CN112584872A/zh active Pending
- 2019-08-14 BR BR112021001691-0A patent/BR112021001691A2/pt unknown
-
2021
- 2021-02-03 IL IL280617A patent/IL280617A/en unknown